Background
Cortisol was isolated from adrenal cortex extracts in the late 1930s. Early animal and clinical work established its role in carbohydrate metabolism and its anti-inflammatory properties. Chemical synthesis of corticosteroids, achieved in the late 1940s and early 1950s, enabled their use as therapeutic agents — a development recognized with the 1950 Nobel Prize in Physiology or Medicine. Subsequent decades brought characterization of circadian secretion, glucocorticoid receptor signaling, and the clinical syndromes of cortisol deficiency (Addison's disease) and excess (Cushing's syndrome), underpinning current diagnostic and replacement strategies.
Evidence snapshot
Cortisol is a pleiotropic glucocorticoid with well-established roles in glucose metabolism, immune modulation, and the physiological stress response. Its circadian regulation by the hypothalamic–pituitary–adrenal (HPA) axis and its permissive and suppressive actions across tissues are thoroughly characterized in the endocrinology literature.
Measurement modalities include serum total cortisol, salivary free cortisol (useful for diurnal profiling and the cortisol awakening response), 24-hour urinary free cortisol (integrated daily secretion), and hair cortisol (retrospective chronic exposure). Each matrix has distinct strengths and limitations for diagnostic versus research applications.
For adrenal insufficiency, hydrocortisone replacement targets physiologic circadian exposure using guideline-recommended daily totals and dose timing. Chronic cortisol excess — whether endogenous (Cushing syndrome) or from long-term exogenous glucocorticoids — produces metabolic, musculoskeletal, and psychiatric morbidity. Single measurements require careful interpretation in context of timing, medications, and clinical status.
Measurement methods and bioavailability
Cortisol circulates predominantly bound to corticosteroid-binding globulin (CBG) and albumin; only the free fraction is biologically active. Serum total cortisol reflects bound and free hormone combined and is the standard clinical measurement. Salivary cortisol correlates closely with free serum cortisol, is collected non-invasively, and is well suited to diurnal profiling and the cortisol awakening response. Twenty-four-hour urinary free cortisol integrates daily secretion and is a preferred screening tool for Cushing syndrome. Hair cortisol provides a retrospective index of cumulative exposure over weeks to months but requires standardized collection protocols and validated laboratory methods to yield reliable results.
Populations and clinical uses studied
Cortisol measurement and replacement have been studied extensively in primary and secondary adrenal insufficiency, Cushing syndrome (both diagnosis and post-treatment monitoring), psychiatric research on stress and depression, and epidemiologic studies of diurnal variation across healthy and clinical populations. Evidence supporting specific replacement dosing largely comes from pharmacokinetic studies, observational data, and consensus guidelines rather than large randomized controlled trials, reflecting the difficulty of placebo-controlled design in hormone replacement settings.
Long-term safety and monitoring
For patients on glucocorticoid replacement, the treatment target is the lowest dose that adequately controls symptoms, to reduce the risk of weight gain, bone loss, and metabolic complications. Long-term supraphysiologic glucocorticoid use warrants bone density monitoring (DEXA), glucose and blood pressure surveillance, and cataract screening. When tapering is planned after prolonged suppression, HPA axis recovery should be assessed with dynamic testing (e.g., short Synacthen test) under specialist supervision. Hair cortisol as an outcome measure in chronic stress research is an active area; associations with health outcomes have been reported but effect sizes vary across studies.
Practical considerations for tracking
Consistent sample timing is the single most important variable when tracking cortisol. Record exact wake time and collection time for every sample; even 30-minute deviations meaningfully affect the cortisol awakening response. Note recent illness, sleep disruption, intense exercise, and any medications taken that morning. For research-style diurnal profiling, multiple saliva samples across the day (e.g., wake, +30 min, +60 min, midday, evening) provide far more information than a single point. Hair samples for chronic exposure assessment are more reliable when collected by trained personnel using standardized proximal-segment protocols.
Compound variations
Hydrocortisone (oral)
The pharmaceutical form of endogenous cortisol used for physiologic replacement in adrenal insufficiency.
Common use case
Adrenal insufficiency replacement therapy.
Dosage note
Typical total daily dose 15–25 mg divided into two or three doses; the larger dose is taken on waking to mirror the physiologic morning peak.
Modified-release hydrocortisone (e.g., Plenadren)
A once-daily formulation designed to better approximate the normal circadian cortisol profile and reduce late-day glucocorticoid exposure compared with immediate-release tablets.
Common use case
Patients requiring physiologic cortisol replacement who may benefit from simplified dosing or improved morning-peak mimicry.
Dosage note
Total daily dose is typically matched to the patient's prior immediate-release dose; individual titration is required.
Prednisone (synthetic glucocorticoid)
A synthetic glucocorticoid prodrug used for anti-inflammatory and immunosuppressive indications. More potent and longer-acting than hydrocortisone.
Common use case
Short- or long-term anti-inflammatory or immunosuppressive therapy under clinician supervision.
Dosage note
Approximately 5 mg prednisone is equivalent in anti-inflammatory potency to 20 mg hydrocortisone. Dosing is indication-specific and individualized.
Dexamethasone
A long-acting, high-potency synthetic glucocorticoid used diagnostically in the dexamethasone suppression test and therapeutically in selected inflammatory and oncologic conditions.
Common use case
Overnight dexamethasone suppression test for Cushing syndrome screening; selected inflammatory or oncologic conditions as directed by a clinician.
Dosage note
1 mg orally at 11 pm is the standard dose for the overnight suppression test. Therapeutic doses vary widely by indication.
Dosage and best practices
Dosage principles
- Adrenal replacement: oral hydrocortisone 15–25 mg/day in divided doses — commonly 10 mg on waking and 5 mg in early afternoon; some patients use a 10/5/5 split — to approximate physiologic circadian exposure (per Endocrine Society clinical practice guidelines).
- Diagnostic testing: the overnight dexamethasone suppression test uses 1 mg oral dexamethasone at 11 pm with serum cortisol measured at 8–9 am to screen for Cushing syndrome. Interpretation requires attention to interfering medications and assay method.
- Sick-day rules in adrenal insufficiency: current guidance commonly advises doubling or tripling the glucocorticoid replacement dose during febrile illness or significant physiologic stress. Severe stress situations (major surgery, sepsis) typically require parenteral hydrocortisone — specific management should follow clinician direction.
Best practices
- Record sample timing relative to wake time. For diurnal profiling, the cortisol awakening response (samples at wake, +30 min, +60 min) is a widely used standard.
- Use salivary or free cortisol measurements for circadian studies; 24-hour urinary free cortisol is preferred when screening for sustained hypercortisolism.
- Disclose all relevant medications and substances before testing — oral contraceptives, anticonvulsants, rifampin, ketoconazole, and exogenous glucocorticoids all alter cortisol levels or assay results.
- For replacement therapy, use the lowest effective dose that resolves symptoms; arrange endocrine follow-up for dose adjustments and periodic bone health assessment.
Literature and references
Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline
The Journal of clinical endocrinology and metabolism • 2016
Consensus guideline covering diagnosis and management of primary adrenal insufficiency, with recommended hydrocortisone replacement ranges (15–25 mg/day) and sick-day and perioperative dosing guidance.
How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions
Endocrine Reviews • 2000
Comprehensive review of glucocorticoid physiology, GR signaling mechanisms, and how cortisol shapes metabolic, immune, and neural responses to stress.
Assessing salivary cortisol in large-scale epidemiological research
Psychoneuroendocrinology • 2009
Reviews practical and methodological considerations in salivary cortisol collection and interpretation for population studies, including timing protocols and assay variability.
Salivary cortisol in psychobiological research: an overview
Neuropsychobiology • 1989
Foundational paper establishing salivary cortisol as a noninvasive index of free cortisol and outlining its applications in stress and psychobiological research.
Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions
Psychoneuroendocrinology • 2012
Review of hair cortisol analysis as a complementary way to monitor stress, noting that it captures systemic cortisol exposure over months whereas saliva and urine cortisol reflect real-time levels.
Common questions
Can I get cortisol from food or supplements?
No. Cortisol is produced by the adrenal glands and is not present in food. Certain substances — caffeine, alcohol, large carbohydrate loads — can transiently alter cortisol secretion, but no dietary intervention reliably raises or lowers baseline cortisol levels to a clinically meaningful degree.
How should I time samples when checking cortisol?
Timing depends on the clinical question. Morning samples around waking (and at +30 and +60 minutes for the cortisol awakening response) are standard for diurnal studies. Twenty-four-hour urine is used to assess total daily secretion. Late-night salivary cortisol or an overnight dexamethasone suppression test is used to screen for Cushing syndrome. Record exact collection times and relevant medications for every sample.
What are typical replacement doses for adrenal insufficiency?
Current guidelines recommend oral hydrocortisone 15–25 mg/day in two to three divided doses — for example, 10 mg on waking and 5 mg in the early afternoon — adjusted to the individual. Modified-release formulations (e.g., Plenadren) deliver once-daily dosing and are designed to better approximate the physiologic morning cortisol peak.
Does chronic stress permanently raise cortisol?
Acute stress produces transient cortisol increases that return to baseline. Chronic psychosocial stress can alter diurnal patterns and is sometimes associated with elevated hair cortisol, but findings across studies are heterogeneous. Persistent HPA axis dysregulation, if present, is usually modest and context-dependent rather than a fixed elevation.
Can salivary cortisol testing replace clinical evaluation?
No. Salivary cortisol is a useful adjunct but must be interpreted alongside clinical assessment, medication review, and, when indicated, confirmatory laboratory testing. Timing errors, oral contamination, and interfering substances are common sources of misleading results.